Status | Study |
Available |
Study Name: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome Condition: Congenital Myasthenic Syndrome Lambert-Eaton Myasthenic Syndrom Date: 2017-02-21 Interventions: Drug: 3,4-Diaminopyridine The investigator will prescribe an initial dose of 3,4 diaminopyridine (DAP) b |
Recruiting |
Study Name: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes Condition: Myasthenic Syndromes, Congenital Date: 2015-09-24 Interventions: Drug: amifampridine phosphate |
Available |
Study Name: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients Condition: Lambert-Eaton Myasthenic Syndrome Congenital Myasthenic Syndrome Date: 2014-07-05 Interventions: Drug: Amifampridine Phosphate Dosage form: tablets contain |
Available |
Study Name: 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM) Condition: Lambert-Eaton Myasthenic Syndrome (LEMS) Congenital Myasthenia Date: 2013-12-11 Interventions: Drug: 3,4-diaminopyridine 10mg tablets for up to 100mg per day |
Available |
Study Name: Treatment Use of 3,4-Diaminopyridine Condition: Lambert Eaton Myasthenic Syndrome (LEMS) Myasthenic Syndromes, Congenital Date: 2013-01-06 Interventions: Drug: 3,4-diaminopyridine Trea |
Completed |
Study Name: Pregnancy Outcomes in Congenital Myasthenie Syndrome Condition: Congenital Myasthenic Syndrome Date: 2011-11-16 |
Recruiting |
Study Name: Congenital Muscle Disease Study of Patient and Family Reported Medical Information Condition: Congenital Muscular Dystrophy (Including Unspecified/Undiagnosed) Dystroglycanopathy Date: 2011-07-26 |
No longer available |
Study Name: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP Condition: Lambert Eaton Myasthenic Syndrome (LEMS) Date: 2011-06-20 Interventions: Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |
Completed |
Study Name: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes Condition: Congenital Myasthenic Syndrome Date: 2010-09-15 Interventions: Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Recruiting |
Study Name: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS) Condition: Lambert-Eaton Myasthenic Syndrome Congenital Myasthenic Syndrome Date: 2009-03-30 Interventions: Drug: 3,4-DIAMINOPYRIDINE Trea |